Skip to main content
. 2010 Apr 26;4:215–225. doi: 10.2147/opth.s9604

Table 3.

Activities of besifloxacin and other antibiotics against anaerobic bacteria21

Species (no of test isolates) and test drug MICa (μg/mL)
Range 50% 90%
Clostridium perfringens (n = 21)
 Besifloxacin 0.12–0.25 0.25 0.25
 Moxifloxacin 0.25–0.5 0.5 0.5
 Gatifloxacin 0.5–1 1 1
 Clindamycin 0.06–4 2 4
 Metronidazole 1–4 2 4
Fusobacterium species (n = 21)
 Besifloxacin 0.12–8 0.25 1
 Moxifloxacin 0.25 to >16 1 2
 Gatifloxacin 0.5 to >16 1 4
 Clindamycin 0.06–8 0.06 2
 Metronidazole ≤0.12–2 0.25 1
Peptostreptococcus species (n = 52)
 Besifloxacin 0.06–2 0.25 0.5
 Moxifloxacin 0.25–4 0.25 0.5
 Ciprofloxacin 0.5 to >8 2 4
 Clindamycin 0.06 to >8 0.25 >8
 Metronidazole ≤0.03 to >16 0.5 1
Propionibacterium acnes (n = 21)
 Besifloxacin 0.12–0.25 0.25 0.25
 Moxifloxacin 0.25–0.25 0.25 0.25
 Gatifloxacin 0.25–0.5 0.25 0.5
 Clindamycin ≤0.03–2 0.06 0.12
 Metronidazole >16 to >16 >16 >16
a

Minimum inhibitory concentration.